Tepotinib With Gefitinib in Participants With Locally Advanced or Metastatic NSCLC (INSIGHT)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
Gossypol Combined With Docetaxel and Cisplatin Scheme in Advanced Non Small-cell Lung Cancers With APE1 High Expression
- Status
- UNKNOWN
- Phase
- PHASE3
Stereotactic Body Radiotherapy Versus Conventional Radiotherapy in Medically-Inoperable Non-Small Lung Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE3
T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab in Combination With Chemotherapy in Patients With Advanced or Recurrent Non-squamous NSCLC
- Status
- COMPLETED
- Phase
- N/A
Phase IV Study of Tarceva in Patients With Advanced Stage IIIB/ IV Non-small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- N/A
Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Gefitinib With or Without Chemotherapy in Brain Metastases From Non-small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*24 Disease Controlled Advanced Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*02 Disease Controlled Advanced Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Time Trends in Waiting Times of NSCLC Patients.
- Status
- WITHDRAWN
- Phase
- N/A
Improving Care After Chemotherapy
- Status
- COMPLETED
- Phase
- NA
Analysis of Treatment Outcome and Toxicity in Non-small Cell Lung Cancer Patients Wither-irradiated to a High Dose for Recurrent Disease
- Status
- COMPLETED
- Phase
- N/A
Usefulness of Blood Biomarkers for Overall Survival in NSCLC
- Status
- COMPLETED
- Phase
- N/A
Phase II Anti-PD1 Epigenetic Therapy Study in NSCLC.
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（ALTER0302）
- Status
- COMPLETED
- Phase
- PHASE2
Stereotactic Precision And Conventional Radiotherapy Evaluation
- Status
- UNKNOWN
- Phase
- NA
A Randomized Phase 2 Study of Atezolizumab (an Engineered Anti-PDL1 Antibody) Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum Therapy - "POPLAR"
- Status
- COMPLETED
- Phase
- PHASE2
Stereotactic Body Radiation Therapy for Inoperable Locally-advanced Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Explore the Individual Treatment of Docetaxel and Paclitaxel in NSCLC, NPC and BRC by PK-guided Dosing Strategy
- Status
- UNKNOWN
- Phase
- NA